Refining Long-Term Prediction of Cardiovascular Risk in Diabetes - The VILDIA Score. - Wikidata - awgldk - TriplyDB

Refining Long-Term Prediction of Cardiovascular Risk in Diabetes - The VILDIA Score.

Refining Long-Term Prediction of Cardiovascular Risk in Diabetes - The VILDIA Score.

http://www.wikidata.org/entity/Q33875341

about

Refining Long-Term Prediction of Cardiovascular Risk in Diabetes - The VILDIA Score.

http://www.wikidata.org/entity/Q33875341

description

2017 nî lūn-bûn

@nan

2017 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Refining Long-Term Prediction of Cardiovascular Risk in Diabetes - The VILDIA Score.

@ast

Refining Long-Term Prediction of Cardiovascular Risk in Diabetes - The VILDIA Score.

@en

type

label

Refining Long-Term Prediction of Cardiovascular Risk in Diabetes - The VILDIA Score.

@ast

Refining Long-Term Prediction of Cardiovascular Risk in Diabetes - The VILDIA Score.

@en

prefLabel

Refining Long-Term Prediction of Cardiovascular Risk in Diabetes - The VILDIA Score.

@ast

Refining Long-Term Prediction of Cardiovascular Risk in Diabetes - The VILDIA Score.

@en

P1433

Q33875341-1037E5B7-543D-495A-9F13-75D384C70DF7

P1476

Q33875341-1580FD31-7D65-4097-89C3-4A395160E438

P2093

Q33875341-30AA5EB9-5E00-4EB7-A492-557DC8880F74

Q33875341-643CD717-1EB6-4BBB-8C13-A7F89D56554F

Q33875341-ACAE3C5F-1D0A-4380-BCFB-B9B319A73F82

Q33875341-AFECC5A6-005F-4E65-B67E-909A988A2499

Q33875341-B2D5D629-87FC-4C4E-9016-02723CFDEFDF

Q33875341-BBC62E75-335C-4EA5-852F-1E7449AE2AEC

P2860

Q33875341-087CC180-62DD-4932-AA0D-0885F8A1AFB5

Q33875341-09EE1DB8-0AB5-4A9E-9E63-86714C73DD02

Q33875341-104541A9-2BCB-49BD-97CB-6F22E8F2CB4D

Q33875341-1919C4AE-7891-4841-A155-B5B2A89F10C4

Q33875341-1D2AD1C9-7D08-42A4-A9D5-10D0AF0068BE

Q33875341-286B1D8D-F314-43C7-B48E-282F609F9454

Q33875341-34C67C0A-D71B-4EE2-8E42-F5ABF1587928

Q33875341-42630865-ABE7-4024-8DEF-F8470CC1905D

Q33875341-4B143E11-BED2-463A-AFEC-D93859989660

Q33875341-5A53366C-D493-4586-B5FA-A1AF5AD0017B

P2888

Q33875341-A6B7033B-283C-4E01-9C2F-B218B6B6E5E0

P304

Q33875341-AF6ED728-4A24-4637-AA6B-94D32A3259C0

P31

Q33875341-47F254AA-5227-49FC-84DA-CC5D75B8EB49

P356

Q33875341-F07E065F-4195-48DD-84F3-2F1948360551

P407

Q33875341-C0DB530A-5E80-4F0F-ABF8-781E7A8D8A07

P433

Q33875341-5715F65E-98A4-485A-A875-FBB2C43D2898

P478

Q33875341-18D0A124-035B-4BFA-85DC-AF3FBB594FFF

P50

Q33875341-6EC1EB4B-7F47-4CBC-85D7-8B6954675425

Q33875341-AB0870C8-9FD6-406B-ACDC-CF91AE74554C

Q33875341-AB747F56-0C63-4CB3-B027-C079374457B6

Q33875341-BA49C8DC-97E1-4E8F-A3D4-D3EE358FB602

Q33875341-C625BEDD-273B-49B2-8F5C-CE52D2721C54

P577

Q33875341-80683B1B-7856-437C-B216-1BDA71AE14F4

P6179

Q33875341-93B884BF-C72A-45EE-9BB3-076424427D3D

P698

Q33875341-903D81B6-A3E8-4577-A24F-6417DD96BCAB

P932

Q33875341-9178AEB7-AAFF-4D3C-9525-4A4849B6EDF8

P356

S41598-017-04935-8

P1433

Scientific Reports

P1476

Refining Long-Term Prediction of Cardiovascular Risk in Diabetes - The VILDIA Score.

@en

P2093

Alexander Niessner

http://www.w3.org/2001/XMLSchema#string

Andreas Tomaschitz

http://www.w3.org/2001/XMLSchema#string

Georg Goliasch

http://www.w3.org/2001/XMLSchema#string

Günther Silbernagel

http://www.w3.org/2001/XMLSchema#string

Philipp E Bartko

http://www.w3.org/2001/XMLSchema#string

Stefan Pilz

http://www.w3.org/2001/XMLSchema#string

P2860

Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development

Prospective association of a genetic risk score and lifestyle intervention with cardiovascular morbidity and mortality among individuals with type 2 diabetes: the Look AHEAD randomised controlled trial.

Platelet-activating factor acetylhydrolase activity indicates angiographic coronary artery disease independently of systemic inflammation and other risk factors: the Ludwigshafen Risk and Cardiovascular Health Study

Cardiorenal end points in a trial of aliskiren for type 2 diabetes

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus.

Lipoprotein-associated phospholipase A2 activity and incident coronary heart disease among men and women with type 2 diabetes

Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies.

Systematic review of guidelines on imaging of asymptomatic coronary artery disease.

Diabetes mellitus, fasting glucose, and risk of cause-specific death.

P2888

s41598-017-04935-8

P304

4700

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-017-04935-8

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Wolfgang Koenig

Marcus E Kleber

Tanja B Grammer

P577

2017-07-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1090352710

http://www.w3.org/2001/XMLSchema#string

P698

28680124

http://www.w3.org/2001/XMLSchema#string

P932

5498499

http://www.w3.org/2001/XMLSchema#string